A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Rocatinlimab
Related studies linked through entity extraction aliases.
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
- Status
- TERMINATED
- Phase
- PHASE2
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- TERMINATED
- Phase
- PHASE3
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
- Status
- COMPLETED
- Phase
- PHASE3